Retrovirally engineered T-cell-based immunotherapy targeting type III variant epidermal growth factor receptor, a glioma-associated antigen
-
- OHNO Masasuke
- Department of Neurosurgery, Nagoya University School of Medicine
-
- NATSUME Atsushi
- Department of Neurosurgery, Nagoya University School of Medicine
-
- IWAMI Ken-ichiro
- Department of Neurosurgery, Nagoya University School of Medicine
-
- IWAMIZU Hidetaka
- Department of Neurosurgery, Nagoya University School of Medicine
-
- NORITAKE Kana
- Department of Neurosurgery, Nagoya University School of Medicine
-
- ITO Daiki
- Department of Neurosurgery, Nagoya University School of Medicine
-
- TOI Yuki
- Department of Neurosurgery, Nagoya University School of Medicine
-
- ITO Motokazu
- Department of Neurosurgery, Nagoya University School of Medicine
-
- MOTOMURA Kazuya
- Department of Neurosurgery, Nagoya University School of Medicine
-
- YOSHIDA Jun
- Department of Neurosurgery, Nagoya University School of Medicine
-
- YOSHIKAWA Kazuhiro
- Center for Genetic and Regenerative Medicine, Nagoya University School of Medicine
-
- WAKABAYASHI Toshihiko
- Department of Neurosurgery, Nagoya University School of Medicine
Search this article
Journal
-
- Cancer Sci
-
Cancer Sci 101 (12), 2518-2524, 2010-12-10
- Tweet
Details 詳細情報について
-
- CRID
- 1572543026128051072
-
- NII Article ID
- 10027834208
-
- NII Book ID
- AA11808050
-
- ISSN
- 13479032
-
- Text Lang
- en
-
- Data Source
-
- CiNii Articles